세계의 만성질환 관리 시장 규모, 점유율, 성장 분석, 질환 유형별, 관리 유형별, 최종 용도별, 기술별, 지역별 - 산업 예측(2025-2032년)
Chronic Disease Management Market Size, Share, and Growth Analysis, By Disease Type (Diabetes, Cardiovascular Diseases), By Management Type (Lifestyle Management, Medication Management), By End Use, By Technology, By Region - Industry Forecast 2025-2032
상품코드:1736983
리서치사:SkyQuest
발행일:2025년 05월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
한글목차
만성질환 관리 세계 시장 규모는 2023년 61억 달러, 2024년 69억 8,000만 달러에서 2032년에는 206억 3,000만 달러로 성장할 것으로 예측되며, 예측 기간(2025-2032년) CAGR은 14.5%를 나타낼 전망입니다.
세계 만성질환 관리 시장은 생활습관 변화에 따른 만성질환 유병률 증가, 특히 도시 지역에서의 만성질환 유병률 증가로 인해 큰 성장세를 보이고 있습니다. 인터넷 접근성 향상으로 건강에 대한 인식이 높아지면서 온라인 건강 정보 및 원격 의료 서비스를 이용하는 사람들이 증가함에 따라 의료기관의 환자 기반이 확대되고 있습니다. 또한, 도시 대기오염은 호흡기 질환 증가로 이어져 만성질환 관리 솔루션에 대한 수요를 더욱 증가시키고 있습니다. 고령화 사회는 노인들이 장기적인 건강 문제를 겪기 쉽기 때문에 고령화 사회는 수요를 더욱 증가시키고 있습니다. 또한, 웰빙 프로그램을 통해 직원들의 건강을 중시하는 기업들이 시장 성장을 가속화하고 있으며, 많은 기업들이 직원들의 건강을 지원하기 위해 만성질환 관리 이니셔티브에 투자하고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
만성질환 관리 시장 규모 : 질환 유형별&CAGR(2025-2032)
시장 개요
당뇨병
심혈관질환
만성 호흡기질환
암
만성 신장병
만성질환 관리 시장 규모 : 관리 유형별&CAGR(2025-2032)
시장 개요
라이프스타일 관리
약물 관리
원격의료 서비스
환자 교육
모니터링 서비스
만성질환 관리 시장 규모 : 최종 용도별&CAGR(2025-2032)
시장 개요
의료 제공자
환자
제약회사
보험회사
연구기관
만성질환 관리 시장 규모 : 기술별&CAGR(2025-2032)
시장 개요
웨어러블 디바이스
모바일 애플리케이션
클라우드 컴퓨팅
전자건강기록
원격의료
만성질환 관리 시장 규모 : 지역별&CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Optum, Inc.(USA)
Medtronic(Ireland)
Koninklijke Philips N.V.(Netherlands)
Abbott Laboratories(USA)
Siemens Healthineers(Germany)
Cognizant(USA)
Infosys Limited(India)
EXL Service Holdings, Inc.(USA)
Epic Systems Corporation(USA)
WellSky(USA)
ZeOmega(USA)
Health Catalyst(USA)
Pegasystems Inc.(USA)
Cerner Corporation(USA)
Humana Inc.(USA)
Teladoc Health, Inc.(USA)
ChartSpan(USA)
Signallamp Health(USA)
Engooden Health(USA)
Optimize Health(USA)
결론과 제안
LSH
영문 목차
영문목차
Global Chronic Disease Management Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.98 billion in 2024 to USD 20.63 billion by 2032, growing at a CAGR of 14.5% during the forecast period (2025-2032).
The global chronic disease management market is experiencing significant growth driven by the rising prevalence of chronic diseases, particularly in urban areas influenced by changing lifestyle patterns. Increased internet accessibility is enhancing health awareness and expanding Healthcare organizations' patient bases as more individuals utilize online health information and telemedicine services. Additionally, urban air pollution is contributing to a rise in respiratory diseases, further elevating the demand for chronic disease management solutions. The aging population adds another layer of demand, as older individuals are more prone to long-term health issues. Moreover, corporate emphasis on employee health through wellness programs accelerates market growth, with many companies investing in chronic disease management initiatives to support their workforce's well-being.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Disease Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Chronic Disease Management Market Segments Analysis
Global Chronic Disease Management Market is segmented by Disease Type, Management Type, End Use, Technology and region. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Cancer and Chronic Kidney Diseases. Based on Management Type, the market is segmented into Lifestyle Management, Medication Management, Telehealth Services, Patient Education and Monitoring Services. Based on End Use, the market is segmented into Healthcare Providers, Patients, Pharmaceutical Companies, Insurance Companies and Research Organizations. Based on Technology, the market is segmented into Wearable Devices, Mobile Applications, Cloud Computing, Electronic Health Records and Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Chronic Disease Management Market
The Global Chronic Disease Management market is experiencing substantial growth driven by rapid digitalization, which is significantly enhancing health awareness among individuals through real-time health monitoring technologies. Innovations such as smartwatches and fitness bands empower users to continuously track vital signs like blood pressure and heart rate, allowing them to monitor their health conditions effectively. As a result, people are increasingly proactive about their well-being, leading to a rise in patient consultations for fitness and health management. This trend underscores the importance of leveraging technology in chronic disease management, fostering a more informed and health-conscious population.
Restraints in the Global Chronic Disease Management Market
While technological advancements in the healthcare sector are significantly benefiting developed economies, several factors could hinder the growth of the global chronic disease management market. In low-income countries, budget limitations pose challenges to effective treatment for chronic diseases. These financial restrictions prevent the adoption of new technologies within their healthcare systems, ultimately affecting medical outcomes. The disparity in resources and lack of infrastructure in these regions can create a substantial barrier to progress, leading to a slower evolution in chronic disease management practices. Therefore, addressing these constraints is essential for achieving equitable healthcare improvements globally.
Market Trends of the Global Chronic Disease Management Market
The Global Chronic Disease Management market is witnessing a significant shift driven by the rapid development and integration of telemedicine and remote monitoring technologies. This trend has been accelerated by the COVID-19 pandemic, highlighting the necessity of efficient healthcare delivery systems. Telemedicine facilitates convenient consultations for patients, particularly in underserved and rural regions, improving access to essential medical services. Furthermore, remote monitoring allows healthcare providers to track symptoms and health indicators in real-time, promoting early interventions that enhance patient outcomes. As a result, the market is poised for growth, characterized by an increasing demand for innovative solutions that enable effective management of chronic diseases.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Chronic Disease Management Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Diabetes
Cardiovascular Diseases
Chronic Respiratory Diseases
Cancer
Chronic Kidney Diseases
Global Chronic Disease Management Market Size by Management Type & CAGR (2025-2032)
Market Overview
Lifestyle Management
Medication Management
Telehealth Services
Patient Education
Monitoring Services
Global Chronic Disease Management Market Size by End Use & CAGR (2025-2032)
Market Overview
Healthcare Providers
Patients
Pharmaceutical Companies
Insurance Companies
Research Organizations
Global Chronic Disease Management Market Size by Technology & CAGR (2025-2032)
Market Overview
Wearable Devices
Mobile Applications
Cloud Computing
Electronic Health Records
Telemedicine
Global Chronic Disease Management Market Size & CAGR (2025-2032)
North America (Disease Type, Management Type, End Use, Technology)
US
Canada
Europe (Disease Type, Management Type, End Use, Technology)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Disease Type, Management Type, End Use, Technology)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Disease Type, Management Type, End Use, Technology)
Brazil
Rest of Latin America
Middle East & Africa (Disease Type, Management Type, End Use, Technology)